Background: Placenta Praevia (PP) is one a significant cause of maternal and perinatal morbidity and mortality. The aim of this study was to to determine the frequency maternal and neonatal outcomes among women with placenta previa. Methods: This cross-sectional study comprised all patients who had a cesarean section for PP at a tertiary referral hospital in Ahvaz, Islamic Republic of Iran, from May 2003 to December 2013. Maternal and neonatal data were obtained from the hospital database System at Obstetrics and Gynecology Department. diagnoses were confirmed during cesarean section. Results: In total, 87 patients with PP were evaluated. 29 patients had complete placenta previas, 33 partial, and 25 low lying placenta previa. 53 cases had previous cesarean sections. 33(37.9%) mothers had to admitted to the intensive care unit and 46(52.9%) mothers need to emergency cesarean. Mean postoperative hospital stay was 5.92 days. In total, 36.8% (n=32) of women underwent an obstetric hysterectomy. frequencies of bladder injuries were 6 (6.9%). postpartum hemorrhage in 37(42.5%) and 34(39.1%) patients were required blood transfusion. The mean packed red blood cell transfusion requirement was 4.4 units. There was no maternal death in this study. During the study period there were 81live births, 6 neonatal deaths, no still birth. Mean gestational age was 34.7 and Mean birth weight of the neonates was 2.5 kgs. There were 25 neonates with an APGAR score of less than 7. three (3.4%) babies were diagnosed as having RDS. 12 cases (13.8%) were diagnosed as small for gestational age and 2(2.2%) cases were IUGR. Conclusion: In our experience partial placenta previa was the most common type of PP. APGAR score <7, was the common neonatal complication and 46(52.9) need to emergency cesarean was the commonest maternal complications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.